Publication of and access to clinical-trial data — update
On 5 December 2013, the Court of Justice of the European Union (CJEU) published its decision on the appeal of the European Medicines Agency (EMA) to the order of the European Union General Court (EGC) for interim measures concerning the access of a third party to documents held by the EMA in relation to an application for authorisation to place a medicinal product on the market. It was reported in November 2013 that, in contrast to the decision of the EMA to grant a third party access to clinical study reports in regard to medicinal products, the EGC had held that the EMA decision be suspended and that the EMA is ordered not to disclose the documents in question…
If you are registered and logged in to the site, click on the link below to read the rest of the Taylor Wessing briefing. If not, please register or sign in with your details below.
Sign in or Register to continue reading this article
It's quick, easy and free!
Why register to The Lawyer
More relevant to you
News from Taylor Wessing
News from The Lawyer
Briefings from Taylor Wessing
For the tax year from 6 April 2014, the standard lifetime allowance has reduced from £1.5m to £1.25m.
One of the areas highlighted last year by the Regulator was the regulation of workplace DC pension schemes.
Analysis from The Lawyer
As the equity capital markets rocketed back into favour and global M&A saw at least a partial return to form, there have been some rich pickings for The Lawyer’s Corporate Team of the Year award shortlisted firms in 2014.
The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world